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ABSTRACT 
Method validation is the process by which it is established that performance characteristics of the method meet the requirements for the intended analytical 
applications. Methods need to be validated or revalidated before their introduction into routine use. The current aim of the research work was to establish a 
simple, rapid and inexpensive method for the estimation of losartan. The parameters linearity, precision, accuracy, limit of detection and limit of quantitation 
were studied according to International Conference on Harmonization guidelines. UV spectroscopic determination was carried out at an absorption maximum 
of 237 nm using distilled water as solvent. In the UV spectroscopic method linearity over the concentration range of losartan was found to be 6-20 µg/ml with 
a correlation coefficient 0.990. Results of the analyses were validated statistically and by recovery studies. The proposed method is simple, rapid, precise and 
accurate and can be used for the reliable quantitation of Losartan in pharmaceutical formulation. 
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INTRODUCTION 
In  the pharmaceutical, medical  device,  food,  blood 
establishments,  tissue  establishments,  and  clinical  trials 
industries, validation is the documented act of demonstrating 
that a procedure, process, and activity will consistently lead 
to  the  expected  results.  The  validity  of  a  specific  method 
should  be  demonstrated  in  laboratory  experiments  using 
samples  or  standards  that  are  similar  to  unknown  samples 
analyzed routinely. There are many reasons for the need to 
validate  analytical  procedures.  Among  them  are  regulatory 
requirements, good science, and quality control requirements. 
The Code of Federal Regulations (CFR) 311.165c explicitly 
states  that  “  the  accuracy,  sensitivity,  specificity,  and 
reproducibility of test methods employed by the firm shall be 
established and documented. ” Of course, as scientists, we 
would  want  to  apply  good  science  to  demonstrate  that  the 
analytical  method  used  had  demonstrated  accuracy, 
sensitivity,  specificity,  and  reproducibility.  Finally 
management of the quality control unit would definitely want 
to ensure that the analytical methods that the department uses 
to release its products are properly validated for its intended 
use so the product will be safe for human use. The accuracy 
of  an  analytical  procedure  expresses  the  closeness  of 
agreement between the value which is accepted either as a 
conventional true value or an accepted reference value and 
the  value  found.  This  is  sometimes  termed trueness
1-3  The 
precision of an analytical procedure expresses the closeness 
of  agreement  (degree  of  scatter)  between  a  series  of 
measurements obtained from multiple sampling of the same 
homogeneous  sample  under  the  prescribed  conditions. 
Precision  may  be  considered  at  three  levels:  repeatability, 
intermediate precision and reproducibility. Precision should 
be  investigated  using  homogeneous,  authentic  samples. 
However,  if  it  is  not  possible  to  obtain  a  homogeneous 
sample  it  may  be  investigated  using  artificially  prepared 
samples or a sample solution. The precision of an analytical 
procedure  is  usually  expressed  as  the  variance,  standard 
deviation  or  coefficient  of  variation  of  a  series  of 
measurements. Losartan potassium is chemically known as 2-
butyl-4-  chloro-1[[2 -(1H-tetrazol-5-yl)[1,1 -biphenyl]-4-
yl]methyl]- 1H-imidazole-5-methanol, which belongs to the 
antihypertensive  group  of  drugs  known  as  angiotensin  II 
receptor antagonists. It is a highly selective and orally active 
non-peptide antagonist used in the treatment of hypertension 
with  heart  failure  or  renal  impairment  by  blocking  the 
binding of angiotensin II to the AT1 receptor level found in 
vascular  smooth  muscles,  adrenal  glands,  etc.  It  is 
metabolized  in  the  body  to  a  pharmacologically  active 
carboxylic  acid  metabolite.  Losartan  competitively  inhibits 
the  binding  of  angiotensin  II  to  AT1  in  many  tissues 
including  vascular  smooth  muscle  and  the  adrenal  glands. 
Losartan  is  metabolized  to  its  active  metabolite,  E-3174, 
which is 10 to 40 times more potent than losartan and acts as 
a non-competitive AT1 antagonist. Inhibition of angiotensin 
II binding to AT1 inhibits its AT1-mediated vasoconstrictive 
and  aldosterone-secreting  effects  and  results  in  decreased 
vascular resistance and blood pressure
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MATERIALS AND METHODS 
UV double beam Spectrophotometer (UV 1700, SHIMADZU 
Limited, Japan) with 1 cm matched quartz cuvetes and digital 
balance. All reagents used were of analytical grade. Double 
distilled water was used throughout the work. 
Methods 
Standard solution of losartan 
Standard  losartan  (100mg)  was  accurately  weighed  and 
transferred  to  100  ml  volumetric  flask.  It  was  dissolved 
properly and diluted up to the mark with distilled water to 
obtain concentration of 1 mg∕ml. This solution was used as 
working  standard  solution.  From  this  solution,  by  suitable 
dilution,  20  µg/ml  concentration  was  obtained  as  standard 
solution for preparation of serial dilutions of 2 -20 µg/ml.  
Measurement of absorbance and calibration curve 
The absorbance of the solutions  containing  Losartan was 
determined in the uv range 100 to 400 nm using appropriate 
blank (distilled water) .The λmax was found to be 237nm .At Tangri Pranshu et al. IRJP 2012, 3 (5) 
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these  wavelength maxima  ,calibration  curve  was  drawn  by 
plotting graph between absorbance and concentration. 
Validation of UV spectrophotometric method
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Linearity The aliquots of concentration ranging 2-20 µg/ml 
were  prepared  in  triplicate,  and  the range  of  linearity  was 
established.  
Precision  
It may be defined as concordance of a series of measurement 
of the same quality .Accuracy expresses the correctness of 
measurement,  while  precision  the  reproducibility  of  a 
measurement. Accuracy without precision is impossible , but 
precision doesn’t imply accuracy. The precision of the assay 
was determined by repeatability (intraday) and intermediate 
precision (interday) and reported as % RSD. For this  4 ,6 8 
µg/m lconcentration solution was measured three times  a day 
and same was measured in next three days. The % RSD was 
calculated (table). 
Accuracy  
Accuracy is defined as the degree of agreement between a 
measured  value  and  the  most  probable  or  true  value. 
Accuracy was determined by performing recovery studies by 
spiking  different  concentrations  of  pure  drug  in  the  pre-
analyzed powder for infusion samples within the analytical 
concentration range of the proposed method at three different 
set at level of 80%, 100% and 120%. The amount of losartan 
was  calculated  at  each  level  and  %  recoveries  were 
computed. 
Limit  of  Detection  (LOD)  and  Limit  of  Quantitation 
(LOQ) 
The  LOD  and  LOQ  were  estimated  from  the  set  of  3 
calibration curves used to determine method linearity. 
LOD= 3.3*σ/S and LOQ= 10*σ/S 
Where, σ = the standard deviation of y-intercepts of 
regression lines, S = the slope of the calibration curve. 
Determination  procedure  for  losartan  potassium  in 
commercial tablets 
For  sample  preparation  of  different  tablets,  the  mixed 
contents of 5.0 tablets were weighed and ground. The powder 
equivalent of 50 mg losartan potassium was stirred well with 
doubly  distilled  water.  The  solution  was  filtered  through 
Whatman  No.  42  filter  paper  (Whatman  International 
Limited, Kent, UK) in a 100.0 mL standard volumetric flask 
and the residue was washed well with doubly distilled water 
for  complete  recovery  of  the  drug.  The  content  of  each 
standard volumetric flask was then diluted to 100.0 mL with 
doubly distilled water. The recovery of the losartan potassium 
was  calculated  from  the  corresponding  linear  regression 
equations or calibration graphs. 
RESULTS AND DISCUSSION 
The  two  simple  methods  inclusive  of  simple  UV-
Spectroscopy  and  second  derivative  spectrophotometric 
methods  were  developed  for  the  estimation  of  losartan 
potassium  in  pharmaceutical  dosage  forms.  The  max  of 
losartan  potassium  was  found  to  be  234nm.  Linearity  was 
found  to  be  6-20μg/ml.  Correlation  coefficient  (0.990) 
indicate good linearity between concentration and slope area. 
The  amplitude  of  the  respective  derivative  spectrum  is 
converted in terms of absorbance. Beer’s law was obeyed by 
the fundamental spectrum. Both the methods were found to 
be simple, accurate, and economical for the routine analysis 
of losartan potassium and its dosage forms. Recovery studies 
were found to be close to 99% that indicated the accuracy and 
precision of the above two proposed methods. values of LOD 
and LOQ were found to be 0.908 and 2.75 respectively. The 
accuracy was calculated to be 98.2%. 
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TABLE 1  calibration curve parameters 
 
 
Concentration  Absorbance± SD   RSD% 
2  0.120± 0.008  6.66 
4  0.160± 0.004  2.50 
6  0.170±0.004  2.35 
8  0.230±0.004  1.73 
10  0.290±0.003  1.03 
12  0.350±0.003  0.85 
14  0.420±0.003  0.71 
16  0.470±0.005  1.06 
18  0.530±0.007  1.32 
20  0.620±0.004  0.64 
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TABLE 2 validation parameters 
S.No  PARAMETER 
 
RESULT 
1  Absorption Maximum(nm)  237 
2  Linearty Range(µg/ml)  2-20 
3  Std.Regression Equation  Y=0.0291x +0.0182 
4  Corelation Coefficient(R2)  0.9902 
5  Accuracy  98.2±0.123 
6  LOD(µg/ml)  0.908 
7  LOQ( µg/ml)  2.75 
 
TABLE 3 INTER DAY(PRECISION) 
s.no.  CONCENTRATION 
( μg/ml) 
ABSORBANCE±SD 
 
%RSD 
 
1.  4  0.162±0.003  1.85 
2.  6  0.177±0.003  1.69 
3.  8  0.237±0.003  1.26 
 
TABLE 4 INTRA DAY(PRECISION) 
S.no.  Conc.  Absorbance ± s.d.  %RSD 
1.  4  0.160±0.004  2.50 
2.  6  0.170±0.004  3.35 
3.  8  0.230±0.004  1.75 
 
Fig. no. Standard curve of losartan 
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